Literature DB >> 25805053

Adverse events following immunization: is this time for the use of WHO causality assessment?

Silvio Tafuri1, Maria Serena Gallone, Giulia Calabrese, Cinzia Germinario.   

Abstract

In recent years, public health authorities in industrialized countries have noted an increase in the numbers of parents choosing not to have their children vaccinated and in the activities of 'antivaccination' movements. Doubts about vaccine safety and lack of surveillance of adverse events following immunization (AEFI) are the most frequent themes proposed by antivaccination movements. This editorial aims to critically analyze the use of AEFI assessment procedures among national health authorities and public health researchers. In fact, the WHO recommended and published a systematic and standardized causality assessment process for serious AEFI, providing a method for individual causality assessment to be used by staff of national immunization programs, regulatory authorities and pharmacovigilance or surveillance departments. The last update was published in March 2013 but to date, an Internet search reveals no information or reports on AEFI surveillance that uses the WHO AEFI causality assessment.

Entities:  

Keywords:  Fluad case; WHO algorithm; adverse events following immunization; causality assessment; postmarketing surveillance

Mesh:

Substances:

Year:  2015        PMID: 25805053     DOI: 10.1586/14760584.2015.1029460

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  6 in total

1.  The public health and the question of the "best vaccine".

Authors:  Silvio Tafuri; Francesco Paolo Bianchi; Pasquale Stefanizzi
Journal:  Vaccine       Date:  2022-05-26       Impact factor: 4.169

2.  Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.

Authors:  Manoochehr Karami; Pegah Ameri; Jalal Bathaei; Zeinab Berangi; Tahereh Pashaei; Ali Zahiri; Seyed Mohsen Zahraei; Hussein Erfani; Koen Ponnet
Journal:  BMC Immunol       Date:  2017-08-23       Impact factor: 3.615

3.  Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017-2018.

Authors:  Pasquale Stefanizzi; Paolo Stella; Domenica Ancona; Katia Nicoletta Malcangi; Francesco Paolo Bianchi; Sara De Nitto; Davide Ferorelli; Cinzia Annatea Germinario; Silvio Tafuri
Journal:  Vaccines (Basel)       Date:  2019-10-07

4.  Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018-2020.

Authors:  Pasquale Stefanizzi; Francesco Paolo Bianchi; Andrea Martinelli; Antonio Di Lorenzo; Paola De Petro; Giusi Graziano; Sabrina Lattanzio; Giusy Diella; Paolo Stella; Domenica Ancona; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2022-02-24       Impact factor: 3.452

5.  Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017.

Authors:  Pasquale Stefanizzi; Sara De Nitto; Francesco Patano; Francesco Paolo Bianchi; Davide Ferorelli; Paolo Stella; Domenica Ancona; Vito Bavaro; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

6.  Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy.

Authors:  Antonio Di Lorenzo; Paola Berardi; Andrea Martinelli; Francesco Paolo Bianchi; Silvio Tafuri; Pasquale Stefanizzi
Journal:  Vaccines (Basel)       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.